CTLA-4, PD-1 and TIM-3 expression predominantly downregulated in MS patients

被引:27
|
作者
Mohammadzadeh, Adel [1 ]
Rad, Isa Abdi [2 ]
Ahmadi-Salmasi, Babak [3 ]
机构
[1] Urmia Univ Med Sci, Dept Immunol & Genet, Orumiyeh, Iran
[2] Urmia Univ Med Sci, Dept Genet, Orumiyeh, Iran
[3] Urmia Univ Med Sci, Dept Neurol, Imam Khomeini Hosp, Orumiyeh, Iran
关键词
CTLA-4; PD-1; TIM-3; Multiple sclerosis; T-CELL-ACTIVATION; MULTIPLE-SCLEROSIS; ASSOCIATION; MECHANISMS; GALECTIN-9; INFECTION; PROMOTES; DISEASE;
D O I
10.1016/j.jneuroim.2018.08.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Multiple sclerosis (MS), is an autoimmune disorder of central nervous system (CNS) characterized by inflammation and demyelination. Self-tolerance impairment is considered to be induced by a combination of inherited susceptibility and environmental agents. In this work, we demonstrate that a reduction in the comparative expression of well-known inhibitory receptors (i.e., CTLA-4, PD-1, and TIM-3) is importantly linked with MS patients compared to healthy controls. The relative expression of interested genes was performed on peripheral blood mononuclear cells (PBMCs), by using quantitative real time-PCR (qRT-PCR). Our data high-lighted the role of inhibitory receptors in the maintenance of immune homeostasis in autoimmune disease.
引用
收藏
页码:105 / 108
页数:4
相关论文
共 50 条
  • [31] Elevated Expression of Tim-3 and PD-1 Immune Checkpoint Receptors on T-CD4+ Lymphocytes of Patients with Asthma
    Mosayebian, Ali
    Koohini, Zohreh
    Hossein-Nataj, Hadi
    Abediankenari, Saeid
    Abedi, Siavash
    Asgarian-Omran, Hossein
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2018, 17 (06) : 517 - 525
  • [32] Functions of CD28, CTLA-4 and PD-1
    Olive, Daniel
    BULLETIN DU CANCER, 2018, 105 : S3 - S15
  • [33] Transcriptional regulation of the immune checkpoints PD-1 and CTLA-4
    Jing Guo
    Zhonghui Xue
    Lie Wang
    Cellular & Molecular Immunology, 2022, 19 : 861 - 862
  • [34] CTLA-4 and PD-1 pathway blockade: combinations in the clinic
    Callahan, Margaret K.
    Postow, Michael A.
    Wolchok, Jedd D.
    FRONTIERS IN ONCOLOGY, 2015, 4
  • [35] PD-1 and CTLA-4: Two checkpoints, one pathway?
    Walker, Lucy S. K.
    SCIENCE IMMUNOLOGY, 2017, 2 (11)
  • [36] Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma
    Kahlmeyer, Andreas
    Stoehr, Christine G.
    Hartmann, Arndt
    Goebell, Peter J.
    Wullich, Bernd
    Wach, Sven
    Taubert, Helge
    Erlmeier, Franziska
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (05)
  • [37] EXPRESSION OF PD-1 AND CTLA-4 IS INCREASED DURING SYMPTOMATIC PHASE OF ACUTE HEPATITIS A
    Kim, C. W.
    Cho, H.
    Kim, H. Y.
    Lee, S. W.
    Jang, J. W.
    Choi, J. Y.
    Yoon, S. K.
    Lee, C. D.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S140 - S141
  • [38] Combination of CTLA-4 and PD-1 blockers for treatment of cancer
    Anand Rotte
    Journal of Experimental & Clinical Cancer Research, 38
  • [39] Expression of PD-1 and CTLA-4 Ligands in Invasive Bladder Cancer Mouse Models
    Allam, M.
    Ismail, N. F.
    Lightbody, R.
    Fraser, S.
    Sansom, O. J.
    Iwata, T.
    JOURNAL OF PATHOLOGY, 2016, 240 : 38 - 38
  • [40] High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer
    Mollavelioglu, Baran
    Aktas, Esin Cetin
    Cabioglu, Neslihan
    Abbasov, Aykhan
    Onder, Semen
    Emiroglu, Selman
    Tukenmez, Mustafa
    Muslumanoglu, Mahmut
    Igci, Abdullah
    Deniz, Gunnur
    Ozmen, Vahit
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)